Chronic Myelomonocytic Leukemia Clinical Trial Pipeline Analysis Demonstrates 22+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
13 août 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Chronic Myelomonocytic Leukemia Clinical Trial Pipeline Analysis Demonstrates 22+ Key Companies at the Horizon Expected to Transform the Treatment...